- Home
- LEN vs BNTX Comparison
LEN vs BNTX Comparison
Compare LEN & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEN
- BNTX
- Stock Information
- Founded
- LEN 1954
- BNTX 2008
- Country
- LEN United States
- BNTX Germany
- Employees
- LEN N/A
- BNTX N/A
- Industry
- LEN Homebuilding
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LEN Consumer Discretionary
- BNTX Health Care
- Exchange
- LEN Nasdaq
- BNTX Nasdaq
- Market Cap
- LEN 31.0B
- BNTX 26.4B
- IPO Year
- LEN N/A
- BNTX 2019
- Fundamental
- Price
- LEN $121.88
- BNTX $104.13
- Analyst Decision
- LEN Hold
- BNTX Strong Buy
- Analyst Count
- LEN 17
- BNTX 13
- Target Price
- LEN $123.40
- BNTX $139.07
- AVG Volume (30 Days)
- LEN 3.5M
- BNTX 731.5K
- Earning Date
- LEN 12-17-2025
- BNTX 11-03-2025
- Dividend Yield
- LEN 1.65%
- BNTX N/A
- EPS Growth
- LEN N/A
- BNTX N/A
- EPS
- LEN 10.16
- BNTX N/A
- Revenue
- LEN $34,766,213,000.00
- BNTX $3,698,814,972.00
- Revenue This Year
- LEN N/A
- BNTX N/A
- Revenue Next Year
- LEN $3.19
- BNTX $9.49
- P/E Ratio
- LEN $11.93
- BNTX N/A
- Revenue Growth
- LEN N/A
- BNTX 3.70
- 52 Week Low
- LEN $98.42
- BNTX $81.20
- 52 Week High
- LEN $174.37
- BNTX $129.27
- Technical
- Relative Strength Index (RSI)
- LEN 44.08
- BNTX 48.24
- Support Level
- LEN $118.94
- BNTX $100.09
- Resistance Level
- LEN $126.91
- BNTX $113.39
- Average True Range (ATR)
- LEN 3.07
- BNTX 3.44
- MACD
- LEN 0.04
- BNTX 0.23
- Stochastic Oscillator
- LEN 26.59
- BNTX 29.43
About LEN Lennar Corporation
Lennar is one of the largest public homebuilders in the United States. The company's homebuilding operations target first-time, move-up, active adult, and luxury homebuyers mainly under the Lennar brand name. Lennar's financial-services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily and single-family for-rent construction and has invested in numerous housing-related technology startups.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.